2026 Dosage Labelling 
The Checkup by Singlecare
FEBRUARY 10, 2025
No generic version of Januvia is available in the United States, but this could change in 2026 when the main patent expires. The first patent, covering the dihydrogen phosphate salt of sitagliptin, expires on November 24, 2026. Polycystic ovary syndrome (PCOS) Januvia can also be prescribed off-label to treat PCOS.
European Pharmaceutical Review
NOVEMBER 24, 2022
With predictions that the global market for anticounterfeiting packaging is set to reach almost $250 billion by 2026, growth in authentication and anti-tamper devices such as holograms appear to have a healthy future.” Elsewhere, holographic labels have been deployed effectively to arrest declining sales of pharmaceuticals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 17, 2022
The second facility for WuXi STA in the US, Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labelling, storage and distribution services for clinical trial materials and commercial drug products.
The Checkup by Singlecare
MARCH 21, 2024
These findings have spurred further research, with ongoing clinical trials set to conclude in October 2026. Dosage and usage of Ozempic for insulin resistance Ozempic is an injectable prescription medicine that is meant to be used alongside diet and exercise for blood sugar control. mg weekly, depending on the condition being treated.
PharmaShots
FEBRUARY 21, 2023
threshold by 2026. FAP-2286 (labeled with lutetium-177), a peptide-targeted radionuclide therapy (PTRT) and imaging agent targeting fibroblast activation protein (FAP), is the company’s lead asset amongst radiopharma products.
Expert insights. Personalized for you.
52 
Let's personalize your content